Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.45 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.42 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19724336 | 0.85 | THRB (0.50) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL7531617 | 0.84 | NPC1 (0.48) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL10538989 | 0.83 | HSD17B10 (0.53) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL18688508 | 0.82 | THRB (0.42) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL472165 | 0.82 | CA12 (0.57) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL9065504 | 0.82 | CA12 (0.57) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL11261082 | 0.81 | SMN1; SMN2 (0.54) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL29168890 | 0.80 | CA12 (0.53) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL29168891 | 0.79 | CA12 (0.51) | NPC1MAPTRAB9APOLBSMN1; SMN2 | |
| SCHEMBL27460918 | 0.79 | GAA (0.50) | NPC1MAPTRAB9APOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239949-A1 | MULTIFUNCTIONAL EPOXY COMPOUND HAVING MULTIPLE LIQUID CRYSTAL CORES, AND CURED PRODUCT PRODUCED THEREFROM | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239949-A1 | MULTIFUNCTIONAL EPOXY COMPOUND HAVING MULTIPLE LIQUID CRYSTAL CORES, AND CURED PRODUCT PRODUCED THEREFROM | ALOX5, ALOX5AP, THEM6 | NPC1 4121/4885MAPT 1139/4885RAB9A 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.